CLABSI Prevention and Compliance Training

The following CLABSI Prevention and Compliance Training educates healthcare providers (HCP) on the definition of CLABSI. Additionally, A central line-associated bloodstream infection (CLABSI) is a laboratory-confirmed bloodstream infection not related to an infection at another site that develops within 48 hours of central line placement.

What you will learn:

• Patient risk factors associated with CLABSI
• Evidence-based practices for central line insertion
• Protocols for the maintenance of central lines
• Methods for identifying CLABSI
• The role of antimicrobial stewardship in preventing CLABSI
• Quality improvement strategies to reduce CLABSI rates
• Strategies for engaging key stakeholders in CLABSI prevention efforts
• An overview of the regulatory requirements related to infection control

Details

Course length: 45 minutes. CME: 0.75

Languages: American English

Key features: Audio narration, learning activity, and post-assessment.

American Medical Compliance is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing education to physicians. Our Continuing Medical Education (CME) program is committed to enhancing the knowledge, skills, and professional performance of healthcare providers to improve healthcare outcomes. Through high-quality educational activities, we aim to address the identified educational gaps to support the continuous professional development of our medical community. American Medical Compliance designates this activity for a maximum of 0.75 AMA PRA Category 1 Credits. Physicians should only claim this credit for their complete participation in this activity.

Get Certified

American Medical Compliance (AMC) is a leader in the industry for compliance, Billing, and HR solutions. To become certified, please visit us at: American Medical Compliance (AMC).

Reach out for other courses by visiting the AMC Course Library.

What are the uses of CLABSIs?

CLABSIs are also the most expensive healthcare-associated infections, costing almost $46,000 per case. Although these infections are extremely expensive, most cases can be avoided with proper aseptic methods, surveillance, and management measures. Furthermore, CLABSIs cause longer hospital stays, higher healthcare expenses, and increased death. In addition, every year, an estimated 250,000 bloodstream infections occur, with the majority of them caused by the presence of intravascular devices. To learn more about these infections and how to further prevent them in your healthcare facility, click the button below.